{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:12:31Z","timestamp":1785337951636,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>The efficacy of psilocybin and other psychedelics as modes of treatment have been demonstrated through clinical trials and other studies in the management of a number of mental illnesses, including some treatment resistant cases. In Psychedelic Assisted Psychotherapy (PAP), psychedelics catalyze or enhance the experience fostered by psychotherapeutic methods. Psychohistoriographic Brief Psychotherapy, conceptualized by the late Professor Frederick Hickling in the 1970\u2032s in Kingston, Jamaica, offers a pathway for exploration in the Jamaican context. Applied to individuals, Psychohistoriographic Brief Therapy (PBT) has already shown success in patients with personality disorders in Jamaica through a process which includes documenting life experiences in a psychohistoriogram. In the De La Haye psilocybin Treatment Protocol (DPTP), micro-doses of crushed, dried psilocybin mushrooms are taken throughout an 8-week outpatient process of documenting the components of the psychohistoriogram, making use of the increased openness and empathy associated with the use of psychedelic agents. These sessions are followed by supervised in-office therapeutic\/mystical doses of crushed, dried psilocybin mushrooms in the 9th week. Given the legal status and availability of psilocybin containing products in a few countries like Jamaica, there is a potential role for a regulated psychedelic industry contributing to the body of useful and rigorous clinical research which is needed in this area. Clients could benefit as we venture into this new frontier in psychiatry.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1136990","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:14:40Z","timestamp":1688080480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective"],"prefix":"10.3389","volume":"14","author":[{"given":"Winston","family":"De La Haye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Walcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhoelle","family":"Beckford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"659044","DOI":"10.3389\/fpsyt.2021.659044","article-title":"Psilocybin: from serendipity to credibility?","volume":"12","author":"Rucker","year":"2021","journal-title":"Front Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/2050324520974484","article-title":"2019: a year of expansion in psychedelic research, industry, and deregulation","author":"Aday","year":"2020","journal-title":"Drug Sci Policy Law."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.32388\/T3EM5E","article-title":"Psychedelic drugs as a long-needed innovation in psychiatry","author":"Ona","year":"2020","journal-title":"Qeios."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiat."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J psychopharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J Psychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0022167817709585","article-title":"Patients' accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J Humanist Psychol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse."},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2021.1916659","article-title":"Exploring the use of psilocybin therapy for existential distress: a qualitative study of palliative care provider perceptions","volume":"54","author":"Mayer","year":"2021","journal-title":"J Psychoact Drugs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0004867421998785","article-title":"Medicinal psychedelics for mental health and addiction: advancing research of an emerging paradigm","volume":"55","author":"Perkins","year":"2021","journal-title":"Aust N Z J Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front Hum Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","article-title":"The entropic brain-revisited","volume":"142","author":"Carhart-Harris","year":"2018","journal-title":"Neuropharmacology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nrleng.2011.07.010","article-title":"Hallucinogenic drugs in pre-Columbia Mesoamerican cultures","volume":"30","author":"Carod-Artal","year":"2015","journal-title":"Neurologia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1556\/2054.2019.008","article-title":"The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: a worldwide overview","volume":"3","author":"Samorini","year":"2019","journal-title":"J Psychedelic Stud."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic psychiatry's brave new world","volume":"18","author":"Nutt","year":"2020","journal-title":"Cell."},{"key":"B24","unstructured":"Convention on Psychotropic Substances.1971"},{"key":"B25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fphar.2018.00733","article-title":"Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development","volume":"9","author":"Schenberg","year":"2018","journal-title":"Front Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3389\/fpsyg.2017.01238","article-title":"Qualitative and quantitative features of music reported to support peak mystical experiences during psychedelic therapy sessions","volume":"8","author":"Barrett","year":"2017","journal-title":"Front Psychol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.17744\/mehc.42.4.03","article-title":"The role of psychedelics and counseling in mental health treatment","volume":"42","author":"Curtis","year":"2020","journal-title":"J Ment Couns."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1176\/ps.40.4.402","article-title":"Sociodrama in the rehabilitation of chronic mentally ill patients","volume":"40","author":"Hickling","year":"1989","journal-title":"Psychiatr Serv."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00086495.1992.11671748","article-title":"Psycho-historiographic analysis of Claude McKay","volume":"38","author":"Hickling","year":"1992","journal-title":"Caribb Q."},{"key":"B33","volume-title":"Psychohistoriography: A Post-Colonial Psychoanalytic and Psychotherapeutic Model.","author":"Hickling","year":"2012"},{"key":"B34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/1363461510364590","article-title":"Psychic centrality: Reflections on two psychohistoriographic cultural therapy workshops in Montreal","volume":"47","author":"Hickling","year":"2010","journal-title":"Transcult Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7727\/wimj.2013.093","article-title":"The treatment of personality disorder in Jamaica with psychohistoriographic brief psychotherapy","volume":"62","author":"Hickling","year":"2013","journal-title":"West Indian Med J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.33552\/OJCAM.2022.08.000676","article-title":"Psychedelics for use and wellbeing cultural context and recent developments: a Jamaican perspective","author":"De La Haye","year":"2022","journal-title":"J Comp Alt Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0245163","DOI":"10.1371\/journal.pone.0245163","article-title":"The use of complementary and alternative medicine among hypertensive and type 2 diabetic patients in Western Jamaica: a mixed methods study","volume":"16","author":"Adeniyi","year":"2021","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctim.2010.01.002","article-title":"The prevalence of herbs use in conjunction with conventional medicines in Jamaica","volume":"18","author":"Delgoda","year":"2010","journal-title":"Comp Ther Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jep.2011.05.025","article-title":"The prevalence of herbal medicine home use and concomitant use with pharmaceutical medicines in Jamaica","volume":"137","author":"Picking","year":"2011","journal-title":"J Ethnopharmacol."},{"key":"B40","first-page":"125","article-title":"Hallucinogens used by Taino Indians in the West Indies","volume":"15","author":"Nieves-Rivera","year":"1995","journal-title":"Atenea."},{"key":"B41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mehy.2018.03.010","article-title":"Out of the box: a psychedelic model to study the creative mind","author":"Kuypers","year":"2018","journal-title":"Med Hypotheses"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"MacLean","year":"2011","journal-title":"J Psychopharmacol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/978-3-319-70134-9_63-1","article-title":"The Jamaican LMIC challenge to the biopsychosocial global mental health model of Western psychiatry","volume-title":"Innovations in Global Mental Health","author":"Hickling","year":"2019"},{"key":"B44","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/B978-0-7020-5101-2.00077-7","article-title":"Plant poisons and traditional medicines","author":"Aronson","year":"2014","journal-title":"Manson's Tropical Infectious Diseases."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1136990\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:14:45Z","timestamp":1688080485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1136990\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":44,"alternative-id":["10.3389\/fpsyt.2023.1136990"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1136990","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1136990"}}